Evaluation of Rational Medicines Use Based on World Health Organization Core Indicators: A Cross-Sectional Study in Five Health Districts in Mauritania

References

• Blum NL. Drug Information Development. A Case Study Nepal. Rational pharmaceutical management project. United States pharmacopoeia; 2000. Available from: http://www.usp.org/pdf/EN/dqi/nepalCaseStudy.pdf. Accessed March 25, 2024.
   Google Scholar
• Ghimire S, Nepal S, Bhandari S, Nepal P, Palaian S. Students’ corner-A prospective surveillance of drug prescribing and dispensing in a teaching hospital in Western Nepal. J Pak Med Assoc. 2009;59(10):726.
   PubMedGoogle Scholar
• World Health Organization. The pursuit of responsible use of medicines: sharing and learning from country experiences. World Health Organization. 2012;2012:1.
   Google Scholar
• World Health Organization. Promoting rational use of medicines: core components; 2002.
   Google Scholar
• Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC Public Health. 2016;16(1):1–14. doi:10.1186/s12889-016-3428-8
   PubMed Web of Science ®Google Scholar
• Bhartiy S, Shinde M, Nandeshwar S, Tiwari S. Pattern of prescribing practices in the Madhya Pradesh, India. Kathmandu University Medical j. 2008;6(1):55–59.
   PubMedGoogle Scholar
• Holloway KA, Ivanovska V, Wagner A, Vialle‐Valentin C, Ross‐Degnan D. Have we improved use of medicines in developing and transitional countries and do we know how to? Two decades of evidence. Tropical Med Intern Health. 2013;18(6):656–664. doi:10.1111/tmi.12123
   PubMed Web of Science ®Google Scholar
• Food DY, Medicine and health care administration and control authority; 2014.
   Google Scholar
• World Health Organization. How to investigate drug use in health facilities: selected drug use indicators; 1993.
   Google Scholar
• World Health Organization. Using indicators to measure country pharmaceutical situations: fact book on WHO level I and level II monitoring indicators. 2006.
   Google Scholar
• Hogerzeil HV, Ross-Degnan D, Laing R, et al. Field tests for rational drug use in twelve developing countries. Lancet. 1993;342(8884):1408–1410. doi:10.1016/0140-6736(93)92760-Q
   PubMed Web of Science ®Google Scholar
• Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, south Ethiopia: a cross-sectional study. BMC Health Serv Res. 2013;13:1–6. doi:10.1186/1472-6963-13-170
   PubMed Web of Science ®Google Scholar
• Ogaji D, Nwaejike D, Ebiekuraju O. Quality of drug prescribing and dispensing practices in primary healthcare centres in an urban local government area in Nigeria. West Afr J Med. 2023;40(9):925–934.
   PubMedGoogle Scholar
• Adeosun SA, Joda AE, Aderemi-Williams RI, Oyetunde OO. Assessment of drug use in primary health centers in Lagos State, Nigeria. Pan Afr Med J. 2022;43:1.
   PubMed Web of Science ®Google Scholar
• Wendie TF, Ahmed A, Mohammed SA. Drug use pattern using WHO core drug use indicators in public health centers of Dessie, north-east Ethiopia. BMC Med Inf Decis Making. 2021;21(1):197. doi:10.1186/s12911-021-01530-w
   PubMed Web of Science ®Google Scholar
• Sisay M, Mengistu G, Molla B, Amare F, Gabriel T. Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study. BMC Health Serv Res. 2017;17(1):1–9. doi:10.1186/s12913-017-2097-3
   PubMed Web of Science ®Google Scholar
• Anagaw YK, Limenh LW, Geremew DT, et al. Assessment of prescription completeness and drug use pattern using WHO prescribing indicators in private community pharmacies in Addis Ababa: a cross-sectional study. J Pharm Policy Prac. 2023;16(1):124. doi:10.1186/s40545-023-00607-3
   PubMed Web of Science ®Google Scholar
• Goruntla N, Ssesanga J, Bommireddy BR, et al. Evaluation of rational drug use based on who/inrud core drug use indicators in a secondary care hospital: a cross-sectional study in western Uganda. Drug Health Patient Saf. 2023;Volume 15:125–135. doi:10.2147/DHPS.S424050
   Web of Science ®Google Scholar
• Siele SM, Abdu N, Ghebrehiwet M, Hamed MR, Tesfamariam EH. Drug prescribing and dispensing practices in regional and national referral hospitals of Eritrea: evaluation with WHO/INRUD core drug use indicators. PLoS One. 2022;17(8):e0272936. doi:10.1371/journal.pone.0272936
   PubMed Web of Science ®Google Scholar
• Akunne OO, Valoyi V, Wehmeyer A, Johnson Y, Coetzee R. Implications of the south African national drug policy on prescribing patterns: a case study of the Limpopo province. J Pharm Policy Prac. 2023;16(1):111. doi:10.1186/s40545-023-00622-4
   PubMed Web of Science ®Google Scholar
• Acam J, Kuodi P, Medhin G, Makonnen E. Antimicrobial prescription patterns in East Africa: a systematic review. Syst Rev. 2023;12(1):18. doi:10.1186/s13643-022-02152-7
   PubMed Web of Science ®Google Scholar
• Mekonnen BD, Ayalew MZ, Tegegn AA. Rational drug use evaluation based on world Health organization core drug use indicators in Ethiopia: a systematic review. Drug Health Patient Saf. 2021;Volume 13:159–170. doi:10.2147/DHPS.S311926
   Web of Science ®Google Scholar
• OMS. Analyse du sous-secteur pharmaceutique Mauritanie; 2020.
   Google Scholar
• Ministere de la santé de Mauritanie. Politique pharmaceutique nationale;2024. Available from: https://www.sante.gov.mr/?wpfb_dl=235#:~:text=La%20Mauritanie%20dispose%20d%27un,de%20santé%20et%2029%20hôpitaux.2022.Accessed March 25, 2024.
   Google Scholar
• Enabel. Extension de la Couverture Maladie Universelle en Mauritanie; 2024. Availble from: https://open.enabel.be/en/MRT/2419/p/extension-de-la-couverture-maladie-universelle-en-mauritanie.html2022. Accessed March 25, 2024.
   Google Scholar
• Accoe K, Marchal B, Gnokane Y, Abdellahi D, Bossyns P, Criel B. Action research and health system strengthening: the case of the health sector support programme in Mauritania, West Africa. Health Res Policy Sys. 2020;18(1):25. doi:10.1186/s12961-020-0531-1
   PubMed Web of Science ®Google Scholar
• Atif M, Sarwar MR, Azeem M, Naz M, Amir S, Nazir K. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res. 2016;16(1):1–9. doi:10.1186/s12913-016-1932-2
   PubMedGoogle Scholar
• Bilal AI, Osman ED, Mulugeta A. Assessment of medicines use pattern using World Health Organization’s prescribing, patient care and health facility indicators in selected health facilities in eastern Ethiopia. BMC Health Serv Res. 2016;16(1):1–8. doi:10.1186/s12913-016-1414-6
   PubMed Web of Science ®Google Scholar
• World Health Organization. Medicines use in primary care in developing and transitional countries: fact book summarizing results from studies reported between 1990 and 2006; 2009.
   Google Scholar
• Massele A, Nsimbi S, Rimoy G. Prescribing habits in church-owned primary health care facilities in Dar-Es-Salaam and other Tanzanian coast Regions. East Afr Med J. 2001;78(10):510–514. doi:10.4314/eamj.v78i10.8958
   PubMedGoogle Scholar
• World Health Organization; Forshaw CJ, Fresle D, Salami AO, Wahab HA. Evaluation of the Nile Province Essential Drugs Project: Mission Report by a WHO Team. Sudan: Bannenberg; 1991.
   Google Scholar
• World Health Organization. Assessment of the pharmaceutical sector in Ethiopia; 2003.
   Google Scholar
• Bergicho M, Mohammed MA, Wabe NT. Assessment of the pattern of drug prescribing in pediatrics ward in tertiary setting hospital in Addis Ababa, Ethiopia. Gaziantep Med J. 2012;18(2):61–65. doi:10.5455/GMJ-30-2012-73
   Google Scholar
• Admassie E, Begashaw B, Hailu W. Assessment of drug use practices and completeness of prescriptions in Gondar University Teaching Referral Hospital. Int J Pharm Sci Res. 2013;4(1):265.
   Google Scholar
• Zimbabwe Mo H. Essential Drugs Action Programme: Essential Drugs Survey. In How to Investigate Drug Use in Health Facilities. Geneva; 1993.
   Google Scholar
• Bimmo. Report on Nigerian field test. INRUD News. 1992;3(1):9–10.
   Google Scholar
• World Health Organization. WHO Access, Watch, Reserve (AWaRe) classification of antibiotics for evaluation and monitoring of use; 2023.
   Google Scholar
• Ofori-Asenso R, Agyeman AA. A review of injection and antibiotic use at primary health care (public and private) centers in Africa. J Pharm Bioallied Sci. 2015;7(3):175. doi:10.4103/0975-7406.160008
   PubMedGoogle Scholar
• Ilbert J F B, Chris J, Fresle D, et al. Evaluation of the Nile province essential drug project. In: How to Investigate Drug Use in Health Facilities. Geneva: World Helath Organization; 1993:1991.
   Google Scholar
• Christensen RF. A strategy for the improvement of prescribing and drug use in rural health facilities in Uganda. In: Ugandan Essential Drugs and Management Program; 2 September-11 October 1990. In How to Investigate Drug Use in Health Facilities. Geneva: World Helath Organization; 1993:74.
   Google Scholar
• Odusanya O. Drug use indicators at a secondary health care facility in Lagos, Nigeria. J Community Med Primary Health Care. 2004;16(1):21–24.
   Google Scholar
• Angamo MT, Wabe NT, Raju N. Assessment of patterns of drug use by using World Health Organization’s prescribing, patient care and health facility indicators in selected health facilities in Southwest Ethiopia. J Appl Pharm Sci. 2011;1:62–66.
   Google Scholar
• Desta Z, Abula T, Beyene L, Fantahun M, Yohannes A, Ayalew S. Assessment of rational drug use and prescribing in primary health care facilities in north west Ethiopia. East Afr Med J. 1997;74(12):758–763.
   PubMed Web of Science ®Google Scholar
• Chedi BA, Abdu-Aguye I, Kwanashie HO. Drug use pattern in out-patient children: a comparison between primary and secondary health care facilities in Northern Nigeria. Afr J Pharm Pharmacol. 2015;9(4):74–81. doi:10.5897/AJPP2014.4262
   Google Scholar
• Sema FD, Asres ED, Wubeshet BD. Evaluation of rational use of medicine using WHO/INRUD core drug use indicators at teda and azezo health centers, Gondar town, northwest Ethiopia. Integrat Pharm Res Pract. 2021;10:51–63. doi:10.2147/IPRP.S316399
   PubMed Web of Science ®Google Scholar
• Nyabuti AO, Okalebo FA, Guantai EM. Examination of WHO/INRUD core drug use indicators at public primary healthcare centers in Kisii County, Kenya. Adv Pharm Sci. 2020;2020:1.
   Web of Science ®Google Scholar
• Bantie L. Assessment of prescribing practice pattern in governmental health centers of Bahir Dar Town, Ethiopia. World Journal of Pharm Sci. 2014;2014:1184–1190.
   Google Scholar
• Bosu W, Ofori-Adjei D. An audit of prescribing practices in health care facilities of the Wassa West district of Ghana. West Afr J Med. 2000;19(4):298–303.
   PubMedGoogle Scholar
• Narendran R, Narendranathan M Influence of pharmaceutical marketing on prescription practices of physicians; 2013.;
   Google Scholar
• Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med. 2007;4(4):e150. doi:10.1371/journal.pmed.0040150
   PubMed Web of Science ®Google Scholar